Maintenance of remission among patients with inflammatory bowel disease after vedolizumab is stopped: a multicenter cohort study from the GETAID

Antoine Martin  ¹     Maria Nachury  ²     Laurent Peyrin-Biroulet  ³     Yoram Bouhnik  ⁴     Stéphane Nancey  ⁵     Philippe Seksik  ⁶     Mélanie Serrero  ⁷     Mathurin Fumery     Anthony Buisson     David Laharie     Cyrielle Gilletta De Saint Joseph     Jerome Filippi     Matthieu Allez     Guillaume Bouguen     Xavier Roblin     Romain Altwegg     Nina Dib     Guillaume Pineton de Chamb    
¹ Henri Mondor Hospital, APHP Dept. of Gastroenterology,Creteil,France
² Lille University Hospital,Lille,France
³ Nancy University Hospital Inserm U 954,Vandoeuvre les Nancy,France
⁴ CHU Beaujon Dept. of IBD and Nutrition,Clichy,France
⁵ Hospices Civils de Lyon,Lyon,France
⁶ Gastroenterology & Nutrition Dept.,Paris,France
⁷ Hopital Nord,

Session
Paradigm shifts in IBD treatment

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019